Sensus Healthcare Inc. (SRTS)
4.73
0.04 (0.85%)
At close: Mar 28, 2025, 3:59 PM
4.75
0.42%
After-hours: Mar 28, 2025, 04:56 PM EDT
0.85% (1D)
Bid | 4.56 |
Market Cap | 78.02M |
Revenue (ttm) | 40.15M |
Net Income (ttm) | 6.38M |
EPS (ttm) | 0.41 |
PE Ratio (ttm) | 11.54 |
Forward PE | 10.78 |
Analyst | Strong Buy |
Ask | 4.77 |
Volume | 124,887 |
Avg. Volume (20D) | 308,643 |
Open | 4.67 |
Previous Close | 4.69 |
Day's Range | 4.57 - 4.76 |
52-Week Range | 3.09 - 9.33 |
Beta | 1.29 |
About SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and s...
Industry Medical - Devices
Sector Healthcare
IPO Date Jul 26, 2016
Employees 54
Stock Exchange NASDAQ
Ticker Symbol SRTS
Website https://www.sensushealthcare.com
Analyst Forecast
According to 3 analyst ratings, the average rating for SRTS stock is "Strong Buy." The 12-month stock price forecast is $13, which is an increase of 174.84% from the latest price.
Stock ForecastsNext Earnings Release
Sensus Healthcare Inc. is scheduled to release its earnings on May 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-32.37%
Sensus Healthcare shares are trading lower after t...
Unlock content with
Pro Subscription
1 month ago
+6.52%
Sensus Healthcare shares are trading lower after the company reported mixed Q4 financial results.